CRISPR THERAPEUTICS AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.24 USD | -1.45% |
|
+6.05% | -10.23% |
| 18/04 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
| 17/04 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |